These findings raised the possibility that VEZT overexpression downregulated the expression of CDC42 and TCF19, upregulated the expression of GPR56, consequently inhibiting invasion, migration and cell proliferation in gastric cancer. Here, ADGRG1 is linked to gastric cancer.